BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

COVID19

Glenmark and Lotus enter into partnership for Ryaltris in key South East Asian markets

Under the terms of the agreement, Glenmark will be responsible for the manufacture and supply of Ryaltris™, while Lotus International Pte. Ltd. will ...

January 20, 2022 | News

Seegene to Launch New COVID-19 PCR Test for Mass Testing

Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics company, announced today the upcoming launch of the Allplex™ SARS-CoV...

January 20, 2022 | News

Australia (TGA) Grants Provisional Registration for Novavax COVID-19 Vaccine

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases,...

January 20, 2022 | News

The Philippines Has Approved ReCOV For Phase II/III Clinical Trial

Recombinant Two-Component COVID-19 Vaccine (ReCOV) was approved for International Phase II/III Clinical Trial ReCOV induced high levels of neutralizing ...

January 18, 2022 | News

Seegene to export COVID-19 test that detects COVID-19 and Omicron

Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics company, announced today that it has delivered over five million COVID...

January 18, 2022 | News

LumiraDx Lab Analysis Confirms its COVID-19 Antigen Test Detects the Omicron Variant

LumiraDx (Nasdaq: LMDX), a next-generation point of care diagnostics company, today announced that results from ongoing testing and monitoring of COVID-19 ...

January 17, 2022 | News

Singapore biotech firm JN Medsys develops a PCR test kit

Singapore-based biotech firm, JN Medsys announces that it has developed a new PCR kit that detects for SARS-CoV-2 and identifies if the Omicron variant is ...

January 13, 2022 | News

LumiraDx receives CE marking after successful CRP test

Quantitative results within 4 minutes of sampling facilitate rapid clinical decision-making at the point of care (POC) LumiraDx (Nasdaq: LMDX),...

January 12, 2022 | News

Singapore scientists awarded Wellcome Leap R3 contract to develop mRNA technology

A team of researchers from A*STAR’s Genome Institute of Singapore (GIS) and Institute of Bioengineering and Bioimaging (IBB), together with the Natio...

January 07, 2022 | News

Aurobindo rolls out molnaflu, oral covid drug for adult patients In India

Molnupiravir was earlier approved under Emergency Use Authorisation from CDSCO, India. This is the first oral antiviral approved by India, the UK agency an...

January 06, 2022 | News

B. subtilis Spores, Biotechnology Breakthrough by DreamTec

Vaccines have been a trending topic ever since the coronavirus outbreak two years ago. DreamTec Research Limited (DreamTec, http://www.dreamtec.hk) ha...

January 05, 2022 | News

Celltrion plans to provide dual treatment options for COVID-19 in South Korea

CT-P63 demonstrated a well- established safety profile in the global Phase I trial CT-P63 maintained strong neutralising ability against the Omicron var...

January 04, 2022 | News

Breakthrough Discoveries on Novel Features of Omicron Variant and An Anti-Omicron Antibody JMB2002

A team of scientists led by Dr. Su-Jun Deng from biologics of Jemincare R&D Center, and another team of scientists from SIMM of CAS, led by P...

January 04, 2022 | News

Ascletis Expands Ritonavir Oral Tablet Production

Ritonavir oral tablet annual production capacity has been expanded to 100 million tablets and can be further rapidly expanded based on market demand - ASC...

January 03, 2022 | News

Stay Connected